Autopsy and Cardiac Magnetic Resonance Image Case of Bevacizumab-Related Cardiomyopathy

被引:3
作者
Hashimoto, Naoki [1 ]
Kitano, Daisuke [1 ]
Tamaki, Takehiro [1 ]
Koyama, Yutaka [1 ,2 ]
Yamada, Akimasa [1 ]
Hatakeyama, Kinta [3 ]
Hao, Hiroyuki [2 ]
Okumura, Yasuo [1 ]
机构
[1] Nihon Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 1738610, Japan
[2] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Human Pathol, Tokyo 1738610, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Osaka 5648565, Japan
关键词
bevacizumab; cardiomyopathy; congestive heart failure; cardiac magnetic resonance imaging; autopsy; FAILURE;
D O I
10.3390/jcdd9070208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report an autopsy case of a 69-year-old female with cervical cancer. She was given bevacizumab-containing chemotherapy for 4 months. After two years of chemotherapy, she developed congestive heart failure (CHF) with left ventricular dysfunction. Cardiac magnetic resonance (CMR) imaging revealed late gadolinium enhancement (LGE) of linear mid-wall delayed enhancement located in the basal to the mid-septal wall, suggesting bevacizumab-related cardiotoxicity. Although she was treated with cardioprotective medications and discharged, she eventually died from worsening CHF a year later, and we conducted an autopsy. Histopathological examination revealed diffuse fibrosis in the myocardium, and the area where LGE was present on CMR showed thinning and wavy changes in cardiomyocytes with diffuse interstitial fibrosis and edema.
引用
收藏
页数:4
相关论文
共 8 条
[1]   Cardiovascular magnetic resonance: applications and practical considerations for the general cardiologist [J].
Arnold, Jayanth Ranjit ;
McCann, Gerry P. .
HEART, 2020, 106 (03) :174-181
[2]   Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy [J].
De Angelis, Giulia ;
De Luca, Antonio ;
Merlo, Marco ;
Nucifora, Gaetano ;
Rossi, Maddalena ;
Stolfo, Davide ;
Barbati, Giulia ;
De Bellis, Annamaria ;
Mase, Marco ;
Santangeli, Pasquale ;
Pagnan, Lorenzo ;
Muser, Daniele ;
Sinagra, Gianfranco .
AMERICAN HEART JOURNAL, 2022, 246 :117-124
[3]   Cardiovascular toxicity of anti-angiogenic drugs [J].
des Guetz, Gaetan ;
Uzzan, Bernard ;
Chouahnia, Kader ;
Morere, Jean-Francois .
TARGETED ONCOLOGY, 2011, 6 (04) :197-202
[4]   Cardiotoxic effects of angiogenesis inhibitors [J].
Dobbin, Stephen J. H. ;
Petrie, Mark C. ;
Myles, Rachel C. ;
Touyz, Rhian M. ;
Lang, Ninian N. .
CLINICAL SCIENCE, 2021, 135 (01) :71-100
[5]   CLINICAL AND MORPHOLOGIC CARDIAC FINDINGS AFTER ANTHRACYCLINE CHEMOTHERAPY - ANALYSIS OF 64 PATIENTS STUDIED AT NECROPSY [J].
ISNER, JM ;
FERRANS, VJ ;
COHEN, SR ;
WITKIND, BG ;
VIRMANI, R ;
GOTTDIENER, JS ;
BECK, JR ;
ROBERTS, WC .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (07) :1167-1174
[6]   Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload [J].
Izumiya, Y ;
Shiojima, I ;
Sato, K ;
Sawyer, DB ;
Colucci, WS ;
Walsh, K .
HYPERTENSION, 2006, 47 (05) :887-893
[7]   Bevacizumab Increases the Risk of Severe Congestive Heart Failure in Cancer Patients: An Up-to-Date Meta-Analysis with a Focus on Different Subgroups [J].
Qi, Wei-Xiang ;
Fu, Shen ;
Zhang, Qing ;
Guo, Xiao-Mao .
CLINICAL DRUG INVESTIGATION, 2014, 34 (10) :681-690
[8]   Cardiovascular Complications of Cancer Therapy Incidence, Pathogenesis, Diagnosis, and Management [J].
Yeh, Edward T. H. ;
Bickford, Courtney L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (24) :2231-2247